Concepedia

D. Vasilcanu

DV

4

Publications

193

Citations

4

H-Index

2005

Active since

Affiliations

Karolinska University Hospital(Current)

Karolinska Institutet

S:t Eriks Ögonsjukhus

Vrije Universiteit Brussel

D. Vasilcanu is an author at Karolinska University Hospital specializing in medicine, cell signaling, and cell biology.

Top concepts

MedicineCell BiologyCell SignalingCell GrowthBiochemistryTumor BiologyCancer ResearchRadiation OncologySignal TransductionMetabolic Regulation

Publications per year

2005–2008

4

Publications

4

Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1

Radu Vasilcanu, D. Vasilcanu, Lars Rosengren et al. · Oncogene · 2007 · 73 citations

Molecular Pharmacology, Potential Mechanistic Involvement, Molecular Physiology +10

Oral Picropodophyllin (PPP) Is Well Tolerated In Vivo and Inhibits IGF-1R Expression and Growth of Uveal Melanoma

Mario A. Economou, Sandra Andersson, D. Vasilcanu et al. · Investigative Ophthalmology & Visual Science · 2008 · 54 citations

The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection

D. Vasilcanu, W-H Weng, Ada Girnita et al. · Oncogene · 2005 · 48 citations

Cancer Research, Growth Hormone, Limited Resistance +10

Oral picropodophyllin (PPP) is well tolerated <i>in vivo</i> and inhibits IGF‐1R expression and growth of uveal melanoma

Mario A. Economou, Sandra Andersson, D. Vasilcanu et al. · Acta Ophthalmologica · 2008 · 18 citations · Full text

Rows per page

1–4 of 4